Regulators say the weight-loss drug Wegovy can now be used to treat more than 3 million overweight Australians with heart ...
TGA occurs when the two main arteries (the aorta and pulmonary ... With proper treatment, many people with congenital heart ...
For the first time in Australia, a weight loss drug has been approved to also treat cardiovascular disease in overweight and obese patients. The ...
For the first time a semaglutide weight loss drug has been approved for use in Australia to also treat cardiovascular disease ...
the TGA approval re-emphasises the equal importance of overweight and obesity as a factor driving heart disease. “Also key is that the risks associated can be reduced, and that there are ...